{"id":"W2890033749","doi":"10.1016/j.jchf.2018.05.021","title":"Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes","year":2018,"lang":"en","type":"review","venue":"JACC Heart Failure","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Takeda Canada; Canadian Diabetes Association; Novo Nordisk; Sanofi; Merck; Heart and Stroke Foundation of Canada; Boehringer Ingelheim; Eli Lilly and Company","keywords":"Medicine; Placebo; Relative risk; Type 2 diabetes; Internal medicine; Randomized controlled trial; Diabetes mellitus; Alogliptin; Type 2 Diabetes Mellitus; Meta-analysis; Cochrane Library; Pharmacology; Sitagliptin; Confidence interval; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004459766,0.000611189,0.003750193,0.0006045728,0.00004131725,0.00002239053,0.0002301916,0.0004525304,0.0003354365],"category_scores_gemma":[0.0001674439,0.0004791359,0.0007053466,0.0008300677,0.00009601164,0.00008061552,0.0001593727,0.0006100628,0.0003472363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000168036,"about_ca_system_score_gemma":0.0002912458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001051563,"about_ca_topic_score_gemma":0.0001053442,"domain_scores_codex":[0.9970234,0.0001518856,0.0011457,0.0006041106,0.00052656,0.0005483652],"domain_scores_gemma":[0.9979314,0.0002561501,0.0005335538,0.0009397322,0.0001145322,0.0002246343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000828589,0.001242669,0.04043294,0.03327087,0.00160592,0.000006357561,0.0005005122,0.000005313691,0.00003771419,0.00006771157,0.5771427,0.3456044],"study_design_scores_gemma":[0.0009566782,0.001236416,0.0007729767,0.02312768,0.001595582,9.645099e-7,0.00009587895,0.000007100026,0.0004762165,0.00001609049,0.9714009,0.0003135055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02017578,0.9757237,0.000001336286,0.0008392702,0.0004150601,0.002120301,0.00004016555,0.00007761624,0.0006067932],"genre_scores_gemma":[0.01039357,0.9793596,0.006907815,0.0001888256,0.0007494101,0.0001026824,0.0004172903,0.0002089037,0.001671915],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3942582,"threshold_uncertainty_score":0.9997661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03524503057917103,"score_gpt":0.3405572229931854,"score_spread":0.3053121924140144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}